Pentixapharm AG: Clinical Trials

4 trials sponsored by Pentixapharm AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 11Recruiting 1
Phase 31Terminated 1

Follow Pentixapharm AG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism
[68Ga]Ga-PentixaFor PET imaging - Primary Aldosteronism
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris202024-06-012024-06-27
[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
[68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose - Marginal Zone Lymphoma
Phase 3TerminatedPentixapharm AG82024-05-202026-04-28
[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients
[90Y]Y-PentixaTher - CNS Lymphoma
Phase 1 / Phase 2RecruitingPentixapharm AG152023-11-072026-06-05
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
68Ga-PTF - CNS Lymphoma
Phase 2TerminatedPentixapharm AG12022-10-052025-09-05

Conditions studied

Hyperaldosteronism (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)

Interventions

68Ga-pentixafor (1)  ·  Fluorodeoxyglucose F18 (1)

Countries

France (3)  ·  Germany (2)  ·  Austria (1)  ·  Denmark (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Andreas Buck, Prof. Dr. (1)  ·  Bastian von Tresckow, Prof. Dr. med. (1)

NIH funding

2023 (1)